These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7509607)

  • 21. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
    Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
    Maccario M; Veldhuis JD; Broglio F; Vito LD; Arvat E; Deghenghi R; Ghigo E
    Eur J Endocrinol; 2002 Mar; 146(3):310-8. PubMed ID: 11888836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy.
    Schaefer S; Vogt T; Nowak T; Kann PH;
    J Neuroendocrinol; 2008 Jan; 20(1):104-9. PubMed ID: 18081558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans.
    Arvat E; Gianotti L; Ramunni J; Grottoli S; Brossa PC; Bertagna A; Camanni F; Ghigo E
    Eur J Endocrinol; 1995 Sep; 133(3):300-4. PubMed ID: 7581945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects.
    Schüle C; Baghai T; Schmidbauer S; Bidlingmaier M; Strasburger CJ; Laakmann G
    Psychoneuroendocrinology; 2004 Feb; 29(2):185-200. PubMed ID: 14604600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
    Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E
    Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles.
    Jacks T; Hickey G; Judith F; Taylor J; Chen H; Krupa D; Feeney W; Schoen W; Ok D; Fisher M
    J Endocrinol; 1994 Nov; 143(2):399-406. PubMed ID: 7830002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects.
    Taylor T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1983 Sep; 57(3):592-6. PubMed ID: 6308033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal growth hormone and cortisol, but not thyroid-stimulating hormone, responses to an intravenous glucose tolerance test in normal-weight, bulimic women.
    Coiro V; Volpi R; Marchesi C; Capretti L; Speroni G; Rossi G; Caffarri G; De Ferri A; Marcato A; Chiodera P
    Psychoneuroendocrinology; 1992 Nov; 17(6):639-45. PubMed ID: 1363137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects.
    Inder WJ; Livesey JH; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):7-13. PubMed ID: 8706296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrinological effects of high-dose Hypericum perforatum extract WS 5570 in healthy subjects.
    Schüle C; Baghai T; Sauer N; Laakmann G
    Neuropsychobiology; 2004; 49(2):58-63. PubMed ID: 14981335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles.
    Hickey G; Jacks T; Judith F; Taylor J; Schoen WR; Krupa D; Cunningham P; Clark J; Smith RG
    Endocrinology; 1994 Feb; 134(2):695-701. PubMed ID: 8299565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion.
    Ambrosio MR; Campo M; Zatelli MC; Cella SG; Trasforini G; Margutti A; Rigamonti AE; Müller EE; degli Uberti EC
    Neuroendocrinology; 1998 Aug; 68(2):123-8. PubMed ID: 9705579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticotropin-releasing hormone is not the sole factor mediating exercise-induced adrenocorticotropin release in humans.
    Smoak B; Deuster P; Rabin D; Chrousos G
    J Clin Endocrinol Metab; 1991 Aug; 73(2):302-6. PubMed ID: 1649838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man.
    Hensen J; Hader O; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1988 Apr; 66(4):668-71. PubMed ID: 2831245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
    Orth DN; Jackson RV; DeCherney GS; DeBold CR; Alexander AN; Island DP; Rivier J; Rivier C; Spiess J; Vale W
    J Clin Invest; 1983 Mar; 71(3):587-95. PubMed ID: 6298280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE; Bonomo SM; Cella SG; Müller EE
    J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans.
    Giordano R; Grottoli S; Brossa P; Pellegrino M; Destefanis S; Lanfranco F; Gianotti L; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):314-20. PubMed ID: 12919154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M; Wiedemann K; Holsboer F
    Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.